amrinone has been researched along with Disease Models, Animal in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Endoh, M | 1 |
| Chen, Y; Hou, X; Qian, Z; Wang, Y; Yuan, J; Zhang, X; Zou, J | 1 |
| Hashimoto, K; Kagawa, H; Kinouchi, K; Ko, Y; Morita, K; Nagahori, R; Shinohara, G | 1 |
| Miura, M; Miwa, Y; Morimoto, S; Ohtsuki, I; Sakato, M; Sasaguri, T; Tadano, N; Takahashi-Yanaga, F; Yoshimura, A; Yoshioka, K | 1 |
| Akcan, A; Akgun, H; Akyýldýz, H; Kucuk, C; Muhtaroglu, S; Sozuer, E | 1 |
| Dodam, JR; Gengo, PJ; Hellyer, PW; Jones, JL | 1 |
| Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
| Cinat, M; Daughters, K; Waxman, K | 1 |
| Dagher, E; Dumont, L | 1 |
| Allen, EM; Dean, JM; Pappas, JB; Rowin, M; Vernon, DD | 1 |
| Beutler, B; Giroir, BP | 1 |
| De Boelpaepe, C; Domb, M; Vincent, JL | 1 |
13 other study(ies) available for amrinone and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Amrinone, forerunner of novel cardiotonic agents, caused paradigm shift of heart failure pharmacotherapy.
Topics: Amrinone; Animals; Calcium Signaling; Cardiotonic Agents; Chronic Disease; Disease Models, Animal; Dogs; Drug Therapy; Heart Failure; Phosphodiesterase 3 Inhibitors; Vasodilation | 2013 |
β2 adrenergic receptor activation governs cardiac repolarization and arrhythmogenesis in a guinea pig model of heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amrinone; Animals; Arrhythmias, Cardiac; Carbazoles; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Electric Stimulation; Electrocardiography; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Guinea Pigs; Heart Failure; In Vitro Techniques; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Pyrroles; Receptors, Adrenergic, beta-2; Thionucleotides; Ventricular Function | 2015 |
Myocardial cyclic AMP augmentation with high-dose PDEIII inhibitor in terminal warm blood cardioplegia.
Topics: Amrinone; Animals; Arrhythmias, Cardiac; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Circulation; Creatine Kinase; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Heart Arrest, Induced; Lipid Peroxidation; Myocardial Reperfusion Injury; Myocardium; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Potassium Compounds; Swine; Time Factors; Troponin T; Up-Regulation; Ventricular Function, Left | 2009 |
SCH00013, a novel Ca(2+) sensitizer with positive inotropic and no chronotropic action in heart failure.
Topics: Amrinone; Animals; Calcium; Cardiotonic Agents; Dihydropyridines; Disease Models, Animal; Dogs; Heart Failure; Heart Rate; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Myocardial Contraction; Myocytes, Cardiac; Pyridazines; Rabbits; Sarcomeres; Stereoisomerism; Ventricular Function, Left | 2005 |
Effects of amrinone in an experimental model of hepatic ischemia-reperfusion injury.
Topics: Adenosine Triphosphate; Alanine Transaminase; Amrinone; Animals; Aspartate Aminotransferases; Biopsy; Calcium; Cyclic AMP; Disease Models, Animal; L-Lactate Dehydrogenase; Liver; Liver Diseases; Male; Phosphodiesterase Inhibitors; Platelet Aggregation; Rats; Rats, Wistar; Reperfusion Injury; Vasodilator Agents | 2009 |
Amrinone combined with dobutamine improves hemodynamics and oxygen delivery without down-regulation of cardiac beta-adrenergic receptor density in porcine endotoxemia.
Topics: Amrinone; Animals; Disease Models, Animal; Dobutamine; Down-Regulation; Drug Therapy, Combination; Hemodynamics; Hydrogen-Ion Concentration; Oxygen Consumption; Radioligand Assay; Receptors, Adrenergic, beta; Shock, Septic; Sodium Bicarbonate; Swine; Ventricular Function, Right | 1995 |
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
Amrinone improves survival in hemorrhagic shock.
Topics: Amrinone; Animals; Blood Pressure; Disease Models, Animal; Drug Evaluation, Preclinical; Infusions, Intravenous; Isotonic Solutions; Male; Oxygen Consumption; Random Allocation; Rats; Rats, Sprague-Dawley; Resuscitation; Ringer's Lactate; Shock, Hemorrhagic; Survival Rate | 1994 |
Effects of amrinone and dobutamine on PGF2 alpha-induced pulmonary hypertension in dogs.
Topics: Amrinone; Animals; Dinoprost; Disease Models, Animal; Dobutamine; Dogs; Drug Therapy, Combination; Hemodynamics; Hypertension, Pulmonary; Respiratory Function Tests | 1994 |
Hemodynamic effects of N-acetylamrinone in a porcine model of group B streptococcal sepsis.
Topics: Amrinone; Animals; Disease Models, Animal; Hemodynamics; Lung; Streptococcal Infections; Streptococcus agalactiae; Swine; Vascular Resistance; Vasodilator Agents | 1996 |
Effect of amrinone on tumor necrosis factor production in endotoxic shock.
Topics: Amrinone; Animals; Cell Line; Chloramphenicol O-Acetyltransferase; Chromatography; Dexamethasone; Disease Models, Animal; Female; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Pentoxifylline; Recombinant Fusion Proteins; Shock, Septic; Tumor Necrosis Factor-alpha | 1992 |
Non-adrenergic inotropic support in septic shock.
Topics: Amrinone; Animals; Disease Models, Animal; Dogs; Hemodynamics; Myocardial Contraction; Shock, Septic | 1987 |